{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:10:01Z","timestamp":1759093801626,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.ijcard.2010.02.060","type":"journal-article","created":{"date-parts":[[2010,3,9]],"date-time":"2010-03-09T04:50:48Z","timestamp":1268110248000},"page":"391-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phentermine cardiovascular safety II: Response to Yosefy Int J Cardiol. 2009 Epub Mar 19"],"prefix":"10.1016","volume":"145","author":[{"given":"Richard B.","family":"Rothman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ed J.","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2010.02.060_bb0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijcard.2004.12.075","article-title":"Cusp tear in bicuspid aortic valve possibly caused by phentermine","volume":"106","author":"Yosefy","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0010","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijcard.2004.12.075","article-title":"Phentermine cardiovascular safety in response to Yosefy C, Berman M, Beeri R. Cusp tear in bicuspid aortic valve possibly caused by phentermine","volume":"106","author":"Rothman","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJMp068265","article-title":"Drugs and valvular heart disease","volume":"356","author":"Roth","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0020","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT(2b) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0025","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199809103391102","article-title":"A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation","volume":"339","author":"Jick","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0030","first-page":"e523","article-title":"2008 Focused Update Incorporated into the ACC\/AHA 2006 Guidelines for the Management of Patients with Valvular Heart Disease: a report of The American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"118","author":"Bonow","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0035","article-title":"Response to ijc-d-08-03075 entitled \u201cPhentermine cardiovascular safety\u201d","author":"Yosefy","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0040","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1161\/CIRCULATIONAHA.107.740878","article-title":"Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community","volume":"117","author":"Michelena","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0045","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/01.CIR.18.3.371","article-title":"Nonpenetrating traumatic injury of the heart","volume":"18","author":"Parmley","year":"1958","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0050","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/0192623307312707","article-title":"Cardiac valvular pathology: comparative pathology and animal models of acquired cardiac valvular diseases","volume":"36","author":"Donnelly","year":"2008","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0055","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archinte.1996.00440120021003","article-title":"The physicians' desk reference. Problems and possible improvements","volume":"156","author":"Cohen","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0060","first-page":"414","article-title":"The diminishing value of the physicians' desk reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs","volume":"4","author":"Burkhart","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0065","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1001\/archinte.161.15.1814","article-title":"Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety","volume":"161","author":"Glazer","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0070","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/oby.2009.69","article-title":"How physician obesity specialists use drugs to treat obesity","volume":"17","author":"Hendricks","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0075","article-title":"Treatment of obesity with \u201cCombination\u201d pharmacotherapy","author":"Rothman","year":"2009","journal-title":"Am J Ther"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0080","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14656560902824152","article-title":"Combination pharmaceutical therapies for obesity","volume":"10","author":"Gadde","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MED.0b013e3283304f90","article-title":"Combination therapy for obesity and metabolic disease","volume":"16","author":"Gadde","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0090","first-page":"180","article-title":"Clinical experience using appetite suppressants and ssris","volume":"101","author":"Rader","year":"2008","journal-title":"J Okla State Med Assoc"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0095","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International primary pulmonary hypertension study group","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0100","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1378\/chest.117.3.870","article-title":"Anorexigens and pulmonary hypertension in the united states: results from the surveillance of north american pulmonary hypertension","volume":"117","author":"Rich","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0105","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1124\/jpet.106.101618","article-title":"Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease","volume":"318","author":"Zolkowska","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijcard.2010.02.060_bb0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2008.11.048","article-title":"Ethical authorship and publishing","volume":"131","author":"Coats","year":"2009","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527310001270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527310001270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:28:31Z","timestamp":1759091311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527310001270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0167527310001270"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2010.02.060","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phentermine cardiovascular safety II: Response to Yosefy Int J Cardiol. 2009 Epub Mar 19","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2010.02.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}